Richard Elledge

13.7k total citations · 4 hit papers
102 papers, 10.0k citations indexed

About

Richard Elledge is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Richard Elledge has authored 102 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 45 papers in Cancer Research and 35 papers in Genetics. Recurrent topics in Richard Elledge's work include Breast Cancer Treatment Studies (34 papers), Estrogen and related hormone effects (28 papers) and HER2/EGFR in Cancer Research (23 papers). Richard Elledge is often cited by papers focused on Breast Cancer Treatment Studies (34 papers), Estrogen and related hormone effects (28 papers) and HER2/EGFR in Cancer Research (23 papers). Richard Elledge collaborates with scholars based in United States, United Kingdom and France. Richard Elledge's co-authors include Gary M. Clark, C. Kent Osborne, Grazia Arpino, D. Craig Allred, Gary C. Chamness, Susan G. Hilsenbeck, William McGuire, Jenny C. Chang, V J Bardou and Syed K. Mohsin and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Richard Elledge

100 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

1993 683 citations D. Craig Allred, Gary M. Clark et al. JNCI Journal of the National Cancer Institute profile →
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

2003 668 citations Jenny C. Chang, Susan G. Hilsenbeck et al. profile →
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

2004 609 citations Grazia Arpino, V J Bardou et al. profile →
Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

2003 565 citations Grazia Arpino, Richard Elledge et al. profile →

Peers

Richard Elledge

ONCOL

GENET

PRM

Elżbieta Senkus Poland

Chad Livasy United States

Lynn G. Dressler United States

Nicholas J. Robert United States

Banu Arun United States

Shinzaburo Noguchi Japan

Karen N. Price Switzerland

Carl Blomqvist Finland

Jennifer K. Litton United States

Joseph A. Sparano United States

Elżbieta Senkus Poland

Richard Elledge

6.2k ×1.0

ONCOL

4.0k ×0.9

2.3k ×0.8

1.8k ×0.7

GENET

2.5k ×1.3

PRM

Citations per year, relative to Richard Elledge Richard Elledge (= 1×) peers Elżbieta Senkus

Countries citing papers authored by Richard Elledge

Since Specialization

Citations

This map shows the geographic impact of Richard Elledge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Elledge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Elledge more than expected).

Fields of papers citing papers by Richard Elledge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Elledge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Elledge. The network helps show where Richard Elledge may publish in the future.

Co-authorship network of co-authors of Richard Elledge

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Elledge. A scholar is included among the top collaborators of Richard Elledge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Elledge. Richard Elledge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Bogang, Huai-Chin Chiang, Haihui Pan, et al.. (2023). BRCA1 deficiency in mature CD8⁺ T lymphocytes impairs antitumor immunity. Journal for ImmunoTherapy of Cancer. 11(2). e005852–e005852. 8 indexed citations

Chiang, Huai-Chin, et al.. (2015). Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers. SHILAP Revista de lepidopterología. 3 indexed citations

Ha, Chul S., Joel Michalek, Richard Elledge, et al.. (2015). p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study. Molecular Oncology. 10(1). 148–156. 9 indexed citations

Massarweh, Suleiman, et al.. (2013). A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure. Breast Cancer Research and Treatment. 143(2). 325–332. 48 indexed citations

Malorni, Luca, Priya B. Shetty, Carmine De Angelis, et al.. (2012). Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Research and Treatment. 136(3). 795–804. 175 indexed citations

Chiang, Huai-Chin, Sreejith J. Nair, I‐Tien Yeh, et al.. (2012). Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier. Experimental Hematology and Oncology. 1(1). 31–31. 8 indexed citations

Elledge, Richard. (2009). Current concepts in research related to oncogenes implicated in salivary gland tumourigenesis: a review of the literature. Oral Diseases. 15(4). 249–254. 9 indexed citations

Blanchard, D. Kay, Priya B. Shetty, Susan G. Hilsenbeck, & Richard Elledge. (2008). Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients. Annals of Surgery. 247(5). 732–738. 167 indexed citations

Friedman, Lois C., Catherine Romero, Richard Elledge, et al.. (2007). Attribution of Blame, Self-forgiving Attitude and Psychological Adjustment in Women with Breast Cancer. Journal of Behavioral Medicine. 30(4). 351–357. 55 indexed citations

10.

Romero, Catherine, Lois C. Friedman, Mamta Kalidas, et al.. (2005). Self-Forgiveness, Spirituality, and Psychological Adjustment in Women with Breast Cancer. Journal of Behavioral Medicine. 29(1). 29–36. 104 indexed citations

11.

Arpino, Grazia, et al.. (2004). Lobular neoplasia on core‐needle biopsy—Clinical significance. Cancer. 101(2). 242–250. 90 indexed citations

12.

Arpino, Grazia, et al.. (2003). Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer. Annals of Oncology. 14(2). 233–241. 24 indexed citations

13.

Chang, Jenny C. & Richard Elledge. (2001). Clinical management of women with genomic BRCA1 and BRCA2 mutations*. Breast Cancer Research and Treatment. 69(2). 101–113. 15 indexed citations

14.

Chang, Jenny C., Richard Elledge, & C. Kent Osborne. (2000). Receptors - Their prognostic and predictive value. 3(2). 62–69. 1 indexed citations

15.

Elledge, Richard, Daniel R. Ciocca, R Pugh, et al.. (1998). HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.. PubMed. 4(1). 7–12. 203 indexed citations

16.

Ciocca, Daniel R., Richard Elledge, Gary M. Clark, et al.. (1998). Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).. PubMed. 4(5). 1263–6. 38 indexed citations

17.

Fabian, Carol J., Bruce F. Kimler, Richard Elledge, et al.. (1998). MODELS FOR EARLY CHEMOPREVENTION TRIALS IN BREAST CANCER. Hematology/Oncology Clinics of North America. 12(5). 993–1017. 40 indexed citations

18.

Elledge, Richard, Gary M. Clark, Gary C. Chamness, & C. Kent Osborne. (1994). Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States. JNCI Journal of the National Cancer Institute. 86(9). 705–712. 357 indexed citations

19.

Allred, D. Craig, Gary M. Clark, Richard Elledge, et al.. (1993). Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 85(3). 200–206. 683 indexed citations breakdown →

20.

Elledge, Richard & William McGuire. (1991). Prognostic factors in axillary node-negative breast cancer. Cancer treatment and research. 61. 3–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact